HTH

HTH is a private Life Science Investment Company. Headquartered in Milan (IT), the company invests worldwide in Biotech, Medtech, Digital Health with a special focus on AI enabled technologies (but not limited to).

Michele Gaiotto

Managing Principal and Founder

2 past transactions

Endostart

Series B in 2021
Endostart develops and manufactures a new generation of medical devices for gastrointestinal endoscopy. It creates Magnetic Balloon Technology, which improves endoscope performance and allows endoscopists to easily meet quality standards. It was founded in collaboration with CNR, public research institutions, and high-tech suppliers.

AirGo

Series A in 2020
My AirGo develops non-invasive medical respiratory sensors designed for real-time minute ventilation and breath dynamics monitoring, providing automated clinical data for critical patient care for physicians. My AirGo is composed of a wearable, miniaturized recorder unit, and a medical grade holter worn over the floating ribs of patients both at rest and during normal activity. The recorder measures live circumference changes. The platform excels at long term live and remote monitoring of patients engaged in regular daily activity, full night sleep sessions, and exercise. Data is processed realtime and the proprietary algorithms can output live alarms and comprehensive diagnostic reports for physicians, enabling them to diagnose patient conditions faster with added precision. All algorithms and DL/ML procedures are already in place, and are being integrated into a GDPR / HIPAA compliant cloud platform for large scale deployment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.